Discovery changed rules
for infant heart transplants
Heart transplants in babies are different from those inadults, thanks to research by cardiologist Dr. Lori West. Shediscovered that infants can receive a heart from a donorwith an incompatible blood type; in adults, donor andrecipient blood types must match. Because infant immunesystems can adapt to a mismatched donor, this widens thepool of potential organs and decreases wait times. West’sdiscovery has changed pediatric heart transplants globally.
Telehealth makes health-care access easier
Alberta has one of the largest and best integratedtelehealth networks in North America, with more than
900 videoconferencing sites. Telehealth makes it easier forAlbertans to use a wide range of specialized health servicessuch as psychiatric care without leaving their hometown.
They don’t have to take days off work to travel and they canremain close to family and friends.
A traditional ingredient becomes
a popular cold medicine
One of Canada’s most popular over-the-counter cold andflu medicines was developed in Alberta. Cold-FX® cameout of research at the University of Alberta on the activeingredients in traditional herbal medicine. It’s derivedfrom the roots of the ginseng plant, one of the most valuedmedicinal plants in the world.
Groundbreaking drug for hepatitis B
The first oral medicine to treat chronic hepatitis B infectionwas developed by Dr. Lorne Tyrrell at the University ofAlberta. Lamivudine is a groundbreaking drug for patientswith this chronic viral infection—about 300 to 350 millionpeople worldwide. These people cannot clear the virus fromtheir body; they are at high risk of serious liver damage, aswell as death from cirrhosis of the liver and liver cancer.Lamivudine stops the virus from replicating, whichminimizes liver damage.